Last reviewed · How we verify
CARBIDOPA; LEODOPA (LEODOPA)
CARBIDOPA; LEODOPA (generic name: LEODOPA) is a drug developed by ZYDUS PHARMS USA INC. It is currently FDA-approved.
At a glance
| Generic name | LEODOPA |
|---|---|
| Sponsor | ZYDUS PHARMS USA INC |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CARBIDOPA; LEODOPA CI brief — competitive landscape report
- CARBIDOPA; LEODOPA updates RSS · CI watch RSS
- ZYDUS PHARMS USA INC portfolio CI
Frequently asked questions about CARBIDOPA; LEODOPA
What is CARBIDOPA; LEODOPA?
CARBIDOPA; LEODOPA (LEODOPA) is a pharmaceutical drug developed by ZYDUS PHARMS USA INC.
Who makes CARBIDOPA; LEODOPA?
CARBIDOPA; LEODOPA is developed and marketed by ZYDUS PHARMS USA INC (see full ZYDUS PHARMS USA INC pipeline at /company/zydus-pharms-usa-inc).
What is the generic name of CARBIDOPA; LEODOPA?
LEODOPA is the generic (nonproprietary) name of CARBIDOPA; LEODOPA.
What development phase is CARBIDOPA; LEODOPA in?
CARBIDOPA; LEODOPA is FDA-approved (marketed).
Related
- Manufacturer: ZYDUS PHARMS USA INC — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing